Agoraphobia diagnosis and treatment market is significantly fueled by aspects like expanding incidence of stress, sedentary lifestyles, genetic disposition, growing screening and awareness, substance abuse, lack of affection in relations, worsening health standards in the modern lifestyles, etc. The factors that restrict the market growth include low focus and penetration of mental health in society, inclination to hide mental ailments, unwillingness to treatment and therapy, social stigma related to psychotherapy, etc. Cognitive behavioral cure is the key psychotherapy for agoraphobia.
Agoraphobia refers to the anxiety related to situations or places that causes panic stricken behavior accompanied by a feeling of being helpless or trapped. The situation might be real or imaginary such as traveling a public conveyance, being present in an enclosed space or being surrounded by a crowd. Symptoms and signs of a panic attack in agoraphobia include troubled breathing, increased heart rate, dizziness, chest pain, feeling of loss of control, excessive sweating, and fear of dying.
Agoraphobia treatment market and concluded that Agoraphobia diagnosis and treatment market is likely to attain $800 mn by the conclusion of 2023. The market is anticipated to develop at a CAGR of 4.3 % over the forecast period 2017-2023.
Regional Analysis
The US market represents a major share of global Agoraphobia treatment sector owing to the outstanding reimbursement set-up, surged outlay on healthcare, and favorable insurance programs. The faster market approval of novel devices and technologies in the US is also a significant driver of the global market for agoraphobia diagnosis and treatment.
The European market holds the second largest share owing to the affluence of the population and their rising awareness about mental health. The Middle East & Africa market is dominated by the Gulf nations specifically UAE and Saudi Arabia.
Market Segmentation
The global agoraphobia market is segmented based on therapy, end-users, and drug treatment. Based on therapy, the market is segmented into exposure therapy, cognitive behavioral therapy (CBT), psychotherapy, and others.
Based on the end users, the market is segmented into academics, clinics, hospitals, and others. Based on drug treatment, the market is segmented into norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, anti-anxiety medications, tricyclic antidepressants, and others.
Request Free Sample Copy of Report with Detailed Impact Analysis of Covid-19:https://www.marketresearchfuture.com/sample_request/4007
Key Players
Global Agoraphobia market is largely dominated by renowned players such as Eli Lilly & Co., Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Sandoz Inc., Pfizer inc, Mylan Pharmaceuticals Inc., and Apotex Corp.
About Market Research Future:
Market Research Future (MRFR) is a world-renowned market research company that offers a wide range of services, complete with accurate and precise analysis about diverse markets, sub-markets and target consumers. Our approach is a combination of extensive information and multiple data sources that help provide an exhaustive comprehension about the latest major developments to the client, in addition to future events and what measures and decisions to take on the basis of the same.
Our fast emerging market research firm is armed with an adept research analysts’ team that focuses on gathering useful data and analytics in terms of economic and technological advances. Our proficient analysts conduct industrial visits in a bid to achieve reliable and accurate information from established market participants. One of our foremost objectives is to keep the client well-versed with all the lucrative opportunities as well as challenges surrounding various global markets. We offer step-by-step guidance to our clients, through consulting and strategic services, enabling them to arrive at a practical and effective decision.